Top Medical Robot Manufacturers & Suppliers in China (2026)
Discover the leading medical robot manufacturers in China. Each company listed below has been verified for product quality, export capability, and after-sales support. Request free quotes to compare pricing directly from the factory.
Tinavi Medical Technologies
ๅคฉๆบ่ช
Est. 2005
๐ Beijing, China
Tinavi Medical Technologies is the pioneer of orthopedic surgical robotics in China, listed on the Shanghai STAR Market. Their flagship TiRobot system was the first domestically developed orthopedic surgical robot to receive NMPA Class III certification, and has been used in over 30,000 surgeries across 200+ hospitals in China.
Orthopedic surgical robotsSpinal surgery navigationTrauma surgery assistance
4 products listed
MicroPort MedBot
ๅพฎๅๅป็ๆบๅจไบบ
Est. 2014
๐ Shanghai, China
MicroPort MedBot is a subsidiary of MicroPort Scientific Corporation, focused on developing surgical robot systems to provide affordable alternatives to imported platforms. Their Toumai laparoscopic robot is positioned as China's answer to the da Vinci system, offering comparable surgical capability at a fraction of the cost with full NMPA approval.
Laparoscopic surgical robotsEndovascular robotsOrthopedic surgical systems
6 products listed
Fourier Intelligence
ๅ ๅฉๅถๆบ่ฝ
Est. 2015
๐ Shanghai, China
Fourier Intelligence is a global rehabilitation robotics company headquartered in Shanghai with offices in Singapore, Germany, and the US. Their ExoMotus series of lower-limb exoskeletons and ArmMotus upper-limb rehabilitation robots are deployed in over 2,000 rehabilitation centers across 40+ countries, making them one of the most internationally recognized Chinese medical robot brands.
Rehabilitation exoskeletonsUpper-limb rehabilitation robotsGait training systems
8 products listed
Remebot (Beijing Baihui Weikang)
ๆๆ ็ปดๅบท
Est. 2010
๐ Beijing, China
Remebot developed China's first NMPA-approved neurosurgical robot for frameless stereotactic procedures including brain biopsies, DBS electrode placement, and epilepsy surgery. The company spun out of research at Beihang University and has established partnerships with leading neurosurgery departments at top-tier Chinese hospitals.
Neurosurgical robotsStereotactic navigationBrain surgery assistance
3 products listed
Siasun Robot & Automation
ๆฐๆพๆบๅจไบบ
Est. 2000
๐ Shenyang, China
Siasun is China's largest publicly listed robotics company, originally focused on industrial automation but expanding into medical robotics with pharmacy automation systems and hospital logistics robots. Their AIVA pharmacy compounding system and autonomous hospital delivery robots are deployed in major hospital networks across China.
UBTECH Robotics is a leading AI and humanoid robotics company that expanded into healthcare with the AIMBOT smart healthcare robot during the COVID-19 pandemic. Their medical service robots combine autonomous navigation with health screening, disinfection, and delivery functions for hospitals, clinics, and eldercare facilities.
Healthcare service robotsTemperature screening robotsHospital logistics
10 products listed
How to Choose a Medical Robot Manufacturer
1. Verify Certifications
Ensure the manufacturer holds relevant certifications such as CE, ISO 9001, and industry-specific standards. These validate product safety and quality management processes.
2. Request Sample Units
Before placing a bulk order, always request a sample or arrange a factory visit. This allows you to verify build quality, performance, and after-sales responsiveness first-hand.
3. Compare After-Sales Support
Evaluate warranty terms, spare parts availability, and technical support options. A reliable manufacturer will offer remote diagnostics, on-site training, and prompt spare parts delivery.
4. Evaluate Export Experience
Choose manufacturers with proven international trade experience. They should be familiar with customs documentation, shipping logistics, and compliance requirements for your target market.
Frequently Asked Questions
How much does a surgical robot system cost from Chinese manufacturers?
Chinese surgical robot systems range from $200,000 to $600,000 depending on the type and complexity. Neurosurgical navigation robots like the Remebot cost $250,000-$400,000. Orthopedic surgical robots such as Tinavi's TiRobot are priced at $350,000-$500,000. Multi-arm laparoscopic systems like MicroPort's Toumai range from $400,000-$600,000 โ still 40-60% less than the Intuitive da Vinci system which typically costs $1.5-$2.5 million. Additional costs include annual maintenance contracts ($20,000-$50,000/year), disposable instruments ($500-$2,000 per procedure), and staff training programs ($10,000-$30,000). Leasing and revenue-sharing models are increasingly available, reducing upfront capital requirements for hospitals.
What certifications do Chinese medical robots need for international markets?
Chinese medical robots require different certifications depending on the target market. For domestic sale in China, NMPA (National Medical Products Administration) registration is mandatory โ Class II for rehabilitation devices and Class III for surgical robots. For the European market, CE marking under the Medical Device Regulation (MDR 2017/745) is required, which involves rigorous clinical evaluation and conformity assessment by a Notified Body. For the US market, FDA 510(k) clearance or Premarket Approval (PMA) is needed depending on the device classification. Additional certifications include ISO 13485 (quality management), IEC 60601 (electrical safety), and ISO 14971 (risk management). Leading Chinese manufacturers like Tinavi, MicroPort, and Fourier Intelligence have obtained multiple international certifications to facilitate global market access.
How do rehabilitation robots help patients recover from stroke?
Rehabilitation robots like the Fourier Intelligence ExoMotus exoskeleton assist stroke patients through repetitive, high-intensity gait training that promotes neuroplasticity โ the brain's ability to rewire neural pathways. The robot provides adjustable levels of assistance, starting with near-full support for severely impaired patients and progressively reducing assistance as the patient's strength and coordination improve (assist-as-needed therapy). Clinical studies show that robot-assisted rehabilitation enables 2-3 times more repetitions per session compared to conventional physiotherapy, leading to faster motor recovery. Real-time gait analysis provides objective metrics on stride length, symmetry, and joint angles, allowing therapists to precisely track progress and adjust treatment protocols. Rehabilitation exoskeletons typically cost $80,000-$150,000, and a single device can serve 6-10 patients per day in a rehabilitation center.
What types of medical robots are manufactured in China?
China manufactures a comprehensive range of medical robots spanning five main categories. Surgical robots include orthopedic systems (Tinavi TiRobot), laparoscopic platforms (MicroPort Toumai), and neurosurgical navigation robots (Remebot). Rehabilitation robots include lower-limb exoskeletons (Fourier ExoMotus), upper-limb training devices (Fourier ArmMotus), and treadmill-based gait trainers. Pharmacy automation robots handle IV compounding, drug dispensing, and prescription fulfillment (Siasun AIVA). Hospital logistics robots autonomously transport medications, lab specimens, meals, and linens between departments (UBTECH, Keenon). Healthcare service robots perform temperature screening, disinfection, patient guidance, and telemedicine functions. The Chinese medical robotics market reached approximately $10 billion in 2024 and is growing at over 25% annually, driven by government healthcare reform policies and an aging population.
Are Chinese surgical robots as precise and safe as imported systems?
Yes, Chinese surgical robots have demonstrated clinical precision and safety comparable to established international systems. Tinavi's TiRobot achieves sub-millimeter accuracy (<0.8mm) for orthopedic screw placement, comparable to the Mazor X system. MicroPort's Toumai features 7-DOF instruments with tremor filtration matching the dexterity of the da Vinci system. These Chinese systems undergo rigorous clinical trials โ the TiRobot completed multi-center randomized controlled trials across 20+ hospitals before receiving NMPA Class III approval. Key safety features include real-time position monitoring, force-limiting mechanisms, emergency stop systems, and redundant sensor arrays. However, Chinese systems currently have shorter track records and smaller global installation bases compared to Intuitive Surgical's da Vinci (over 7,000 units worldwide). Hospitals should evaluate clinical evidence, surgeon training support, and after-sales service networks when comparing systems.
How do pharmacy automation robots reduce medication errors?
Pharmacy automation robots like the Siasun AIVA system reduce medication errors through multiple verification layers. Barcode scanning verifies each drug vial against the electronic prescription before compounding begins. Gravimetric (weight-based) checking confirms the exact volume of each drug drawn, with accuracy to ยฑ0.05ml. Automated labeling and routing prevent mix-ups between patient-specific IV bags. These systems achieve dispensing error rates below 0.01%, compared to manual compounding error rates of 1-5% reported in hospital pharmacy literature. Beyond accuracy, pharmacy robots protect staff from occupational exposure to hazardous drugs like chemotherapy agents by handling all cytotoxic compounding within sealed cleanroom enclosures. A single pharmacy robot can process 150-200 IV bags per hour, replacing 4-6 manual compounding stations while maintaining consistent sterile technique around the clock.
What factors should hospitals consider when purchasing a medical robot?
Hospitals evaluating medical robot purchases should consider several critical factors. Clinical evidence โ review published clinical trial data and real-world outcomes from hospitals already using the system. Regulatory status โ confirm NMPA, CE, or FDA approval for the specific indications your hospital intends to use. Total cost of ownership โ calculate not just the purchase price but also annual maintenance ($20,000-$80,000), disposable instrument costs per procedure ($500-$3,000), and required facility modifications (power, space, networking). Training and support โ evaluate the manufacturer's surgeon training program duration and quality, and confirm local technical support availability for maintenance and troubleshooting. Case volume requirements โ most surgical robots need a minimum of 100-200 cases per year to achieve cost-effectiveness and maintain surgeon proficiency. Integration capability โ verify compatibility with your hospital's existing PACS, HIS, and surgical scheduling systems. Technology roadmap โ assess the manufacturer's R&D pipeline and commitment to software updates and instrument development.